 1 Agents affecting nervous system and sensory organs
|
11 Agents affecting central nervous system
|
 111 General anesthetics
|
112 Hypnotics and sedatives, anxiolytics
|
1121 Organic bromines
|
 1122 Meprobamates
|
1123 Chloral hydrates
|
1124 Benzodiazepins
|
D00293 Diazepam (JP18/USP/INN)
D00267 Chlordiazepoxide (JP18/USP/INN)
D01292 Medazepam (JP18/INN)
D00694 Clorazepate dipotassium (JP18/USP)
D00365 Lorazepam (JP18/USP/INN)
D01245 Bromazepam (JP18/USAN/INN)
D00225 Alprazolam (JP18/USP/INN)
D01354 Fludiazepam (JP18/INN)
D01293 Ethyl loflazepate (JP18/INN)
D01268 Cloxazolam (JP18/INN)
D01254 Tofisopam (JP18/INN)
D01316 Mexazolam (JAN/INN)
D01408 Flurazepam hydrochloride (JP18)
D00531 Nitrazepam (JP18/USAN/INN)
D01230 Flunitrazepam (JP18/USAN/INN)
D00311 Estazolam (JP18/USP/INN)
D00387 Triazolam (JP18/USP/INN)
D01657 Lormetazepam (JAN/USAN/INN)
D00550 Midazolam (JAN/USP/INN)
D01744 Brotizolam (JP18/USAN/INN)
D00457 Quazepam (JAN/USP/INN)
D01278 Oxazolam (JP18/INN)
D01286 Flutazolam (JAN/INN)
D01758 Haloxazolam (JP18/INN)
|
1125 Barbiturates and thiobarbiturates
|
1126 Bromides
|
1127 Angelica root and Cnidium rhizome
|
1129 Others
|
113 Antiepileptics
|
114 Antipyretics and analgesics, anti-inflammatory agents
|
115 Stimulants
|
116 Antiparkinsonian agents
|
117 Psychotropics
|
118 Common cold drugs
|
119 Miscellaneous
|
12 Agents affecting peripheral nervous system
|
13 Agents affecting sensory organs
|
19 Other agents affecting nervous system and sensory organs
|
|
2 Agents affecting individual organs
|
|
3 Agents affecting metabolism
|
|
4 Agents affecting cellular function
|
|
5 Crude drugs and Chinese medicine formulations
|
|
6 Agents against pathologic organisms and parasites
|
|
7 Agents not mainly for therapeutic purpose
|
|
8 Narcotics
|
Therapeutic Category of Drugs in Japan